Policy Notices

• Reminder of Upcoming FORMS-F and Inclusion Across the Lifespan Requirements for NIH Applicants and Recipients Submitting Post-Submission Updates Using the Human Subjects System (HSS)
  (NOT-OD-20-125)
  National Institutes of Health
  

• NIH Summary Statement Available to the Signing Officials (SO) through the eRA Commons
  (NOT-OD-20-126)
  National Institutes of Health
  

General Notices

• NIAID Late Application Policy for NIAID-Specific FOAs with Due Dates in July and August 2020
  (NOT-AI-20-054)
  National Institute of Allergy and Infectious Diseases
  

• Notice of Informational Webinar on the Intramural NIGMS Postdoctoral Research Associate Training (PRAT) Program and Fi2 Application Process
  (NOT-GM-20-037)
  National Institute of General Medical Sciences
  

• Notice of Information for Date of Submission to NOT-MD-20-019 and NIMHD Consideration for FY Award.
  (NOT-MD-20-024)
  National Institute on Minority Health and Health Disparities
  

• Changes to Handling of Applications Submitted to Program Announcements with special Receipt, Referral, and/or Review Considerations (PAR) and Program Announcements with Set-Aside Funds (PAS)
  (NOT-OD-20-114)
  National Institutes of Health
  

• Notice of Pre-Application Webinar for the RADx-UP Initiative
  (NOT-OD-20-131)
  National Institutes of Health
  Office of Disease Prevention
  

• Request for Information (RFI): Enhancing Rigor, Transparency, and Translatability to Improve Biomedical Research Involving Animal Models
  (NOT-OD-20-130)
  National Institutes of Health
  

• Request for Information: Challenges and Opportunities in Improving our Understanding of Transposable Elements and Somatic Mosaicism
  (NOT-RM-20-020)
  Office of Strategic Coordination (Common Fund)
  

Notice of Changes to Funding Opportunities

• Notice of Change to NIA-Specific Text in RFA-OD-19-029 "The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)"
  (NOT-AG-20-037)
  National Institute on Aging
  

• Notice of NEI's Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
  (NOT-EY-20-010)
  National Eye Institute
  

• Notice of Change to Target FOA and Expiration Date of NOT-HL-19-678 "Notice of Special Interest (NOSI): Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases"
  (NOT-HL-20-797)
  National Heart, Lung, and Blood Institute
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for "BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)"
  (NOT-MH-20-062)
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Neurological Disorders and Stroke
  

Notices of Special Interest

• Notice of Specialist Interest (NOSI): Advancing Polycystic Kidney Disease (PKD) Research through Catalytic Tool and Technology Development
  (NOT-DK-20-034)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Special Interest (NOSI) in Research on Risk and Prevention of Black Youth Suicide
  (NOT-MH-20-055)
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  Office of Disease Prevention
  

• Notice of Special Interest (NOSI): Common Fund ALS-related Transformative Research Award (R01 Clinical Trial Optional)
  (NOT-RM-20-019)
  Office of Strategic Coordination (Common Fund)
  National Institute on Aging
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Neurological Disorders and Stroke
  

• Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need
  (NOT-TR-20-029)
  National Center for Advancing Translational Sciences
  

Funding Opportunities

• Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
  (PAR-20-212)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of Mental Health
  Application Receipt Date(s): Only accepting applications for the AIDS Due Date(s) listed below.
  
  

• HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
  (PAR-20-231)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of Allergy and Infectious Diseases
  National Institute of Mental Health
  Application Receipt Date(s): Only accepting applications for the AIDS application receipt dates listed below.
  
  

• Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed)
  (PAR-20-232)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is October 16, 2020
  
  

• Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed)
  (PAR-20-233)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply The first standard due date for this FOA is October 5, 2020
  
  

• NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)
  (PAR-20-234)
  National Institute on Aging
  Application Receipt Date(s): July 1, 2020; August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; and February 1, 2021.
  
  

• Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia (R01 Basic Experimental Studies with Humans Required)
  (PAR-20-235)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is October 5, 2020
  
  

• Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)
  (PAR-20-237)
  National Institute on Minority Health and Health Disparities
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Nursing Research
  Office of Disease Prevention
  Office of Research on Women's Health
  Application Receipt Date(s): August 28, 2020; December 1, 2020
  
  

• Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
  (RFA-AG-21-023)
  National Institute on Aging
  Application Receipt Date(s): November 13, 2020. No late applications will be accepted for this funding opportunity announcement.
  
  

• Martin Delaney Collaboratories for HIV Cure Research (UM1 Clinical Trial Not Allowed)
  (RFA-AI-20-035)
  National Institute of Allergy and Infectious Diseases
  National Heart, Lung, and Blood Institute
  National Institute on Drug Abuse
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
  
  

• Martin Delaney Collaboratory for Pediatric HIV Cure Research (UM1 Clinical Trial Not Allowed)
  (RFA-AI-20-036)
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Mental Health
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
  
  

• Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional)
  (RFA-DA-21-009)
  National Institute on Drug Abuse
  National Cancer Institute
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Application Receipt Date(s): October 19, 2020 No late applications will be accepted for this Funding Opportunity Announcement.
  
  

• Laboratory, Data Analysis, and Coordinating Center (LDACC) for the Developmental Genotype-Tissue Expression Project(U24) (Clinical Trial Not Allowed)
  (RFA-HG-20-039)
  National Human Genome Research Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Research on Women's Health
  Application Receipt Date(s): November 13, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  
  

• Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01 - Clinical Trials Required)
  (RFA-HL-21-001)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): December 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  
  

• Regional Medical Libraries for the Network of the National Library of Medicine (UG4)
  (RFA-LM-20-001)
  National Library of Medicine
  Application Receipt Date(s): September 11, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.